Please login to the form below
Amgen appoints Wanda Austin to its Board
She will also serve as a member of the firm's audit committee
Amgen has appointed Wanda Austin to its board of directors and as a member of its audit committee and corporate responsibility and compliance committee.
Austin most recently retired from her role as president and chief executive officer of space programme The Aerospace Corporation, where she has served from 2008 to 2016.
Robert Bradway, chairman and chief executive officer, Amgen, said: “We are pleased to welcome Dr Wanda Austin to Amgen’s board.
“Wanda’s deep experience in long-cycle technology and engineering settings and her senior leadership experience will be invaluable to Amgen.”
The addition of Austin will see Amgen’s board comprise of 14 directors, 13 of whom are independent of the company.
Featured jobs
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Account Manager
-
Negotiable
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Senior Writer, Healthcare Advertising, London
-
Excellent package
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
- Account Director or Senior Account Director
-
Salary TBC
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
-
Healthcare PR Senior Account Manager
-
Salary TBC
Subscribe to our email news alerts
- Bluebird’s first gene therapy gets European fast track
- NHS wins legal fight with pharma over off-label Avastin
- Gilead and ViiV among winners at PM Society Digital Awards
- Moving annual total (MAT)
- J&J files ‘breakthrough’ bladder cancer drug in US
- After Lucentis setback, Novartis trumpets data on follow-up drug
- AstraZeneca chief on Brexit: “It’s going to be really painful”
- Roche’s Tecentriq misses survival mark in frontline NSCLC
- Amarin hits jackpot with astonishing heart benefits from fish oil product
- Novartis cuts manufacturing jobs in Switzerland and UK
- New Awards scheme for medical and scientific professionals
- Random42 Exhibiting at BioCap Conference 2018
PMHub
GCI Health
GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...
Latest intelligence
- Solaris Health looks at the gene therapy revolution
- Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
Quick links
Infographics
